Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 8Neoplasms 6Head and Neck Neoplasms 6Prostatic Neoplasms 5Oropharyngeal Neoplasms 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Neoplasm Metastasis 4Myasthenia Gravis 4Lymphoma, Large B-Cell, Diffuse 4Cholangiocarcinoma 4Recurrence 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Fatigue 3Endometrial Neoplasms 3Carcinoma 3Breast Neoplasms 3Weight Loss 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2

Interventions

nilutamide 1luprolide acetate gel depot 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Salicylic Acid 1Radiation 1Leuprolide 1Goserelin 1Flutamide 1Docetaxel 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Stage I Prostate Adenocarcinoma AJCC v7 × 30 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡